Anaphylactic reaction to polyethylene‐glycol conjugated‐asparaginase: Premedication and desensitization may not be sufficient
Anaphylactic reaction to polyethylene‐glycol conjugated‐asparaginase: Premedication and desensitization may not be sufficient
复制标题
对聚乙二醇结合天冬酰胺酶的过敏反应:术前用药和脱敏可能还不够
DOI:
10.1111/ped.12131
复制
发表时间:
2013
影响因子:
1.4
通讯作者:
C. Saçkesen
中科院分区:
文献类型:
--
作者:
U. Sahiner;S. T. Yavuz;M. Gökçe;B. Buyuktiryaki;Ilhan Altan;S. Aytaç;M. Tuncer;A. Tuncer;C. Saçkesen
In hypersensitive reactions to native L‐asparaginase, either premedication and desensitization or substitution with polyethylene glycol conjugated asparaginase (PEG‐ASP) is preferred. Anaphylaxis with PEG‐ASP is rare. An 8‐year‐old girl and a 2.5‐year‐old boy, both diagnosed as having acute lymphoblastic leukemia, presented with native L‐asparaginase hypersensitivity and substitution with PEG‐ASP was preferred. They received a premedication (methylprednisolone, hydroxyzine and ranitidine) followed by desensitization with PEG‐ASP infusion. Both patients developed anaphylaxis with peg‐asparaginase. These are the first reported cases of anaphylactic reaction to PEG‐ASP, despite the application of both premedication and desensitization. Anaphylaxis with PEG‐ASP is very rare and premedication and desensitization protocols may not prevent these hypersensitive reactions.